News

The small-scale study on Chinese macaques was conducted by Mymetics at the Institute of Laboratory Animal Science (ILAS) in Beijing in collaboration with Cochin Institute and INSERM, Paris

Diartis Pharmaceuticals also acquired the clinical-stage diabetes drug candidate VRS-859 (exenatide-XTEN) from Versartis and will use this initial funding to continue developing therapeutics for type 2 diabetes mellitus

Sativex is an endocannabinoid system modulator made up principally of two active ingredients -THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol). Sativex, administered as an oral spray, is specifically designed for

iBIO Institute orchestrates business leadership in the service of educational programs and job-creating technology startups. PROPEL helps to guide the development of formation-stage and early-stage life sciences companies

The new patent covers DNA vaccines containing codon-optimized versions of genes encoding gB and CMV phosphoprotein 65 (pp65) antigens, and adds to Vical‘s family of patents in the

Sucanon is one of only three approved drugs for a class of diabetic medications called ‘Insulin Sensitizers’ in the multi-billion dollar market. It lowers a patient’s blood sugar

CogniSure is the sole US dietary supplement that has Colostrinin, the only colostrum-derived, protein-rich polypeptide (PRP) complex shown to influence brain aging mechanisms and to support adult cognitive

Auralgan Otic Solution is a prescription drug used to treat pain and inflammation associated with ear infections. According to the FDA, the sale of Auralgan in the US

SC MabThera has been developed through collaboration between Halozyme and Roche, in which Halozyme has agreed to apply its proprietary Enhanze technology to Roche’s biological therapeutic compounds. MabThera